What are the indications, recommended dosing, contraindications, adverse effects, and alternative treatments for amoxicillin?

Amoxicillin: Clinical Overview

Indications

Amoxicillin is a first-line penicillin-class antibiotic indicated for multiple bacterial infections across all age groups. 1

Primary Indications in Adults and Children:

• Respiratory tract infections: Community-acquired pneumonia (CAP), acute bacterial rhinosinusitis (ABRS), acute otitis media
• Upper respiratory infections: Ear, nose, and throat infections
• Skin and soft tissue infections
• Genitourinary tract infections
• Helicobacter pylori infection with duodenal ulcer disease (adults only) 1

Specific Clinical Scenarios:

For Community-Acquired Pneumonia:

• Outpatient CAP (children <5 years): Amoxicillin 90 mg/kg/day in 2 doses is preferred first-line therapy 2
• Outpatient CAP (children ≥5 years and adults): Amoxicillin 90 mg/kg/day (maximum 4 g/day) 2, 3
• Inpatient CAP: Ampicillin or penicillin G preferred for fully immunized children; amoxicillin for step-down therapy 2

For Acute Bacterial Rhinosinusitis:

• Amoxicillin is the drug of choice for both children and adults due to efficacy, low cost, and narrow spectrum 4, 5, 4
• High-dose amoxicillin-clavulanate (90 mg/kg amoxicillin component) recommended for treatment failure or high-resistance areas 4

For Lyme Disease:

• Amoxicillin 500 mg three times daily (adults) or 50 mg/kg/day in 3 divided doses (children, maximum 500 mg/dose) for early Lyme disease 6

---

Recommended Dosing

Adults:

• Standard dosing: 750-1750 mg/day in divided doses every 8-12 hours 1
• CAP: 1 g three times daily 3
• H. pylori triple therapy: 1 g twice daily with clarithromycin 500 mg and lansoprazole 30 mg for 14 days 1
• H. pylori dual therapy: 1 g three times daily with lansoprazole 30 mg for 14 days 1

Pediatric Patients (>3 months):

• Standard dosing: 20-45 mg/kg/day in divided doses every 8-12 hours 1
• High-dose for resistant organisms: 90 mg/kg/day in 2 divided doses (maximum 4 g/day) 2, 7
• CAP: 90 mg/kg/day in 2 doses 2
• Acute sinusitis: 90 mg/kg/day in 2 doses (high-dose amoxicillin-clavulanate if β-lactamase producing organisms) 8

Neonates and Infants ≤3 months:

• Maximum dose: 30 mg/kg/day divided every 12 hours due to immature renal function 1

Renal Impairment:

• GFR 10-30 mL/min: 250-500 mg every 12 hours 1
• GFR <10 mL/min: 250-500 mg every 24 hours 1
• Hemodialysis: 250-500 mg every 24 hours, with additional dose during and after dialysis 1
• Do NOT use 875 mg dose if GFR <30 mL/min 1

Duration of Therapy:

• Most infections: Continue 48-72 hours beyond symptom resolution, typically 10-14 days 4
• Non-severe CAP in children: 5 days is adequate 7, 9
• Lyme disease: 10-21 days depending on manifestation 6

---

Contraindications

Amoxicillin is absolutely contraindicated in patients with a history of serious hypersensitivity reactions to amoxicillin or other β-lactam antibiotics. 1

Specific Contraindications:

• Anaphylaxis to penicillins or cephalosporins 1
• Stevens-Johnson syndrome or other severe cutaneous adverse reactions (SCAR) from β-lactams 1
• History of penicillin hypersensitivity with severe reactions 1

Relative Contraindications/Cautions:

• Infectious mononucleosis: High percentage develop erythematous rash; avoid use 1
• Pregnancy: Generally safe, but avoid doxycycline alternatives 6
• Severe renal impairment: Requires dose adjustment 1

---

Adverse Effects

Common Adverse Effects (>1%):

• Diarrhea (most common) 1
• Rash 1
• Vomiting 1
• Nausea 1

Serious Adverse Effects:

Anaphylactic Reactions:

• Serious and occasionally fatal anaphylaxis reported, more common with parenteral therapy but occurs with oral formulations 1
• More likely in patients with penicillin hypersensitivity history or multiple allergen sensitivities 1

Severe Cutaneous Adverse Reactions (SCAR):

• Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), DRESS syndrome, acute generalized exanthematous pustulosis (AGEP) 1
• Monitor closely and discontinue if lesions progress 1

Clostridioides difficile-Associated Diarrhea (CDAD):

• Can range from mild diarrhea to fatal colitis 1
• Consider in all patients with diarrhea following antibiotic use 1
• May occur >2 months after administration 1

Adverse Reaction Rates:

• Amoxicillin prophylaxis: 0 fatal reactions per million prescriptions, 22.62 non-fatal reactions per million 10
• Postmarketing surveillance: 3.6% total adverse event incidence in pediatric patients, no serious events 11
• Gastrointestinal effects: Less frequent with twice-daily versus three-times-daily dosing 11

---

Alternative Treatments

For Penicillin-Allergic Patients:

Respiratory Infections:

• Macrolides: Azithromycin (10 mg/kg day 1, then 5 mg/kg days 2-5) or clarithromycin (15 mg/kg/day in 2 doses) 2, 3
• Respiratory fluoroquinolones (adults): Levofloxacin 750 mg daily, moxifloxacin, or gemifloxacin 3, 12
• Doxycycline (>8 years): 2-4 mg/kg/day in 2 doses 2, 3
• Cephalosporins: Cefuroxime, cefpodoxime, cefdinir (use cautiously if severe penicillin allergy) 4

Lyme Disease:

• Doxycycline: 100 mg twice daily (adults); 4 mg/kg/day in 2 doses (children ≥8 years) 6
• Cefuroxime axetil: 500 mg twice daily (adults); 30 mg/kg/day in 2 doses (children) 6

When Amoxicillin Fails:

For Resistant Organisms or Treatment Failure:

• High-dose amoxicillin-clavulanate: 90 mg/kg/day amoxicillin component with 6.4 mg/kg clavulanate in 2 doses 4, 11
• Second-generation cephalosporins: Cefuroxime axetil 4
• Third-generation cephalosporins: Cefpodoxime, cefdinir, ceftriaxone (parenteral) 4
• Respiratory fluoroquinolones (adults with comorbidities): Moxifloxacin, levofloxacin 750 mg 3

Important Considerations:

Macrolide Resistance:

• In regions with >25% high-level macrolide-resistant S. pneumoniae, consider alternatives even for patients without comorbidities 3
• Never use macrolide monotherapy for bacterial pneumonia in HIV-infected patients due to increased drug-resistant S. pneumoniae risk 12

Fluoroquinolone Cautions:

• Active against Mycobacterium tuberculosis; use cautiously when TB suspected to avoid masking diagnosis and promoting resistance 12
• Not routinely recommended for children due to FDA contraindication for <18 years 13

Ineffective Alternatives:

• First-generation cephalosporins (e.g., cephalexin): Inactive against B. burgdorferi and many respiratory pathogens 6, 13
• Trimethoprim-sulfamethoxazole: Increasing resistance in children; check local resistance patterns 4

---

Key Clinical Pearls

Formulation and Administration:

• Dispersible tablets (250 mg, 500 mg): WHO-recommended child formulation for ease of administration and dose accuracy 9
• Oral suspension: Shake well before use; refrigeration preferable but not required; discard after 14 days 1
• Food: Does not significantly affect absorption 14

Monitoring:

• Clinical improvement expected within 48-72 hours; if no improvement or deterioration, reassess diagnosis and consider complications 2
• For SCAR: Monitor skin closely and discontinue if rash progresses 1
• For CDAD: Evaluate any diarrhea occurring during or after treatment 1

Common Pitfalls:

• Mononucleosis: Do not use amoxicillin; high risk of rash 1
• Severe renal impairment: Avoid 875 mg dose; adjust frequency based on GFR 1
• Treatment duration: Ensure completion of full course (typically 10-14 days for most infections, 5 days for uncomplicated pediatric CAP) 4, 7, 9
• High-dose formulations: Use 90 mg/kg/day for resistant organisms, not standard 40-45 mg/kg/day 2, 11, 15